West Pharmaceutical Services Inc. (WST)
WST trades on NYSE in Health Care, Medical/Dental Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$371.82
+1.15% on the day
Market cap
$26.2B
Large cap
Revenue · 2025
$3.1B
+6.3% on 2024
Net income · 2025
$493.7M
16.1% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | WST on NYSE |
| Sector | Health Care |
| Industry | Medical/Dental Instruments |
| Country | United States |
| IPO year | Not reported by the screener |
| SEC CIK | 0000105770 |
| SEC industry code | Surgical & Medical Instruments & Apparatus |
| Incorporated in | PA |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $3.1B |
| Net income | $493.7M |
| Operating income | $584.9M |
| Net margin | 16.1% |
| Operating margin | 19.0% |
| Revenue growth | +6.3% |
| Cash | $791.3M |
| Total assets | $4.3B |
| P/E (computed) | 53.0× |
| P/S (computed) | 8.5× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest annual report | 10-K | 2026-02-17 |
| Latest quarterly / interim | 10-Q | 2026-07-23 |
| Latest current report | 8-K | 2026-07-23 |
| Latest proxy | DEFA14A | 2026-03-12 |
Source: SEC EDGAR submissions feed, 1,000 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | +2.2% |
| 1 month | +2.6% |
| 3 months | +3.4% |
| Year to date | +36.2% |
| 1 year | +42.7% |
| From 52-week high | -0.6% |
Source: Yahoo Finance daily closes, last bar 2026-10-14. Computed by Sophia Capital from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Medical/Dental Instruments
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| DXCM | DexCom Inc. | $85.06 | -1.00% | $32.1B |
| RMD | ResMed Inc. | $235.04 | +0.19% | $33.1B |
| SOLV | Solventum Corporation | $86.30 | +1.16% | $14.7B |
| MDLN | Medline Inc. | $35.70 | -0.17% | $46.9B |
| BDX | Becton Dickinson and Company | $187.37 | -0.81% | $51.0B |
| BAX | Baxter International Inc. | $24.89 | +0.44% | $12.9B |
| PEN | Penumbra Inc. | $320.01 | -0.30% | $12.6B |
| BSX | Boston Scientific Corporation | $43.31 | -1.21% | $62.8B |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier